Document Detail


The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling.
MedLine Citation:
PMID:  15860547     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The CTRdelta e13 splice variant of the rabbit calcitonin receptor, which lacks the 14 amino acids of the seventh transmembrane domain (TMD) that are encoded by exon 13, is poorly expressed on the cell surface, fails to mobilize intracellular calcium or activate Erk, and inhibits the cell surface expression of the full-length C1a isoform. Nuclear magnetic resonance- and fluorescence-activated cell sorter-based experiments showed that the residual seventh TMD of CTRdelta e13 fails to partition into the lipid bilayer, resulting in an extracellular C terminus. Truncating the receptor after residue 397 to delete the cytoplasmic tail resulted in reduced cell surface expression and an inability to mobilize intracellular calcium or activate Erk, but the truncated receptor did not inhibit C1a cell surface expression. In contrast, when the receptor was truncated after residue 374 to eliminate the entire seventh TMD domain and the C-terminal domain, the resulting receptor reduced the cell surface expression of C1a in a manner similar to that of CTRdelta e13. Thus, normal cell surface expression, mobilization of intracellular calcium, and Erk activation requires the cytoplasmic C-terminal tail of the CTR, whereas the absence of the seventh TMD in the transmembrane helical bundle causes the dominant-negative effect on the surface expression of C1a.
Authors:
Thomas Seck; Maria Pellegrini; Ana Maria Florea; Veronique Grignoux; Roland Baron; Dale F Mierke; William C Horne
Related Documents :
11056047 - Tissue-specific expression of antisense and sense transcripts at the imprinted gnas locus.
3664637 - Inactivation of transcription by uv irradiation of t. brucei provides evidence for a mu...
15386737 - Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle ind...
11992647 - Induction of udp-glucuronosyltransferase 1a8 mrna by 3-methylcholanthene in rat hepatom...
10202107 - Rapid expression of il-1beta by intestinal epithelial cells in vitro.
16115217 - Extracellular signal-regulated kinases (erks) modulate cocaine-induced gene expression ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.     Date:  2005-04-28
Journal Detail:
Title:  Molecular endocrinology (Baltimore, Md.)     Volume:  19     ISSN:  0888-8809     ISO Abbreviation:  Mol. Endocrinol.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-07-25     Completed Date:  2005-12-02     Revised Date:  2011-09-26    
Medline Journal Info:
Nlm Unique ID:  8801431     Medline TA:  Mol Endocrinol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2132-44     Citation Subset:  IM    
Affiliation:
Yale University School of Medicine, Department of Orthopaedics, New Haven, Connecticut 06520, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blotting, Western
Calcium / metabolism
Cell Line
Cell Membrane / metabolism
Cell Separation
Cyclic AMP / metabolism
Cytoplasm / metabolism
DNA / metabolism
Enzyme Activation
Extracellular Signal-Regulated MAP Kinases / metabolism
Flow Cytometry
Genes, Dominant
Humans
Immunoprecipitation
Magnetic Resonance Spectroscopy
Peptides / chemistry
Phosphorylation
Protein Folding
Protein Isoforms
Protein Structure, Tertiary
Rabbits
Receptors, Calcitonin / chemistry*,  metabolism
Signal Transduction
Temperature
Transfection
Grant Support
ID/Acronym/Agency:
AR-49879/AR/NIAMS NIH HHS; DE-04724/DE/NIDCR NIH HHS; GM-54083/GM/NIGMS NIH HHS; R01 AR049879-01/AR/NIAMS NIH HHS; R01 AR049879-02/AR/NIAMS NIH HHS; R01 AR057769-02/AR/NIAMS NIH HHS; R01 GM054082-08/GM/NIGMS NIH HHS; R01 GM054082-09/GM/NIGMS NIH HHS; R37 DE004724-24/DE/NIDCR NIH HHS
Chemical
Reg. No./Substance:
0/Peptides; 0/Protein Isoforms; 0/Receptors, Calcitonin; 60-92-4/Cyclic AMP; 7440-70-2/Calcium; 9007-49-2/DNA; EC 2.7.11.24/Extracellular Signal-Regulated MAP Kinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Female steroid hormones use signal transducers and activators of transcription protein-mediated path...
Next Document:  Gene regulatory potential of nonsteroidal vitamin D receptor ligands.